MCDA approach to ranking rare diseases in Russia: preliminary results VK Fedyaeva, VV Omelyanovsky, O Rebrova, N Khan, EV Petrovskaya Value in Health 17 (7), A539, 2014 | 15 | 2014 |
Meditsinskie tekhnologii O Rebrova, V Fedyaeva, G Khachatryan Otsenka i vybor 4 (14), 8-14, 2013 | 15 | 2013 |
Adaptation and validation of the questionnaire for the assessment of risk of bias in randomized controlled trials R OYu, VK Fedyaeva, GR Khachatryan Meditsinskie tekhnologii. Otsenka i vybor 1, 9-17, 2015 | 10 | 2015 |
The Questionnaire to Assess the Risk of Systematic Bias in Non-Randomized Comparative Studies: the Russian-Language Version of the Newcastle-Ottawa Scale R OYu, VK Fediaeva Assessment and Choice 3 (25), 14-9, 2016 | 9 | 2016 |
A systematic review of the clinical effectiveness of monitoring patients with diabetes mellitus using individual blood glucose meters with function of transmitting measurements … VK Fedyaeva, NI Zhuravlev, ZA Galeeva Diabetes mellitus 22 (4), 328-335, 2019 | 6 | 2019 |
Meta-analyzes and evaluation of their methodological quality OY Rebrova, VK Fedyaeva Russian version of the AMSTAR questionnaire. Expert Opinion Must be on High …, 2016 | 6 | 2016 |
The use of QALY as an integral measure of effectiveness in the evaluation of medical technologies NZ Musina, VK Fedyaeva FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 10 (1 …, 2017 | 5 | 2017 |
Analysis of government procurements of medicines for rare diseases in Russia D Fedyaev, VK Fedyaeva, VV Omelyanovskiy Value in Health 18 (7), A677, 2015 | 5 | 2015 |
Guidelines on the application of multi-criteria analysis in health care VV Omel'yanovskii, VK Fedyaeva, OY Rebrova Expert Health Council of the Federation Council Committee on Social Policy …, 2014 | 5 | 2014 |
The concept of multicriteria analysis of decision-making in the current system of health technology assessment in Russia.[Koncepciya mnogokriterial'nogo analiza prinyatiya … VV Omelyanovsky, VK Fedyaeva, NZ Musina Russ.). https://doi. org/10.17749/2070-4909.2018, 11.3-003, 0 | 5 | |
Concept of value-based healthcare NZ Musina, VV Omelyanovskiy, RV Gostischev, OA Sukhorukikh, ... FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 13 (4 …, 2021 | 4 | 2021 |
Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies TS Teptsova, TP Bezdenezhnyh, VK Fedyaeva, NZ Musina, ... FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 11 (3 …, 2018 | 4 | 2018 |
Review of the current approaches to the assessment of the drug innovative potential worldwide NZ Musina, VK Fedyaeva, VV Omel’yanovskii, GR Khachatryan, ... FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 10 (3 …, 2017 | 4 | 2017 |
Metody rascheta QALY kak integral’nogo pokazatelya effektivnosti v protsesse kompleksnoy otsenki lekarstvennyh preparatov NZ Musina, VK Fedyaeva FARMAkoekoNoMIkA. Sovremennaya farmakoekonomika i farmakoepidemiologiya …, 2017 | 4 | 2017 |
Application of Multiple-Criteria Analysis for Optimization of Financing of Rare Diseases VV Omelyanovskiy, VK Fedyaeva, OY Rebrova FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 7 (4), 29-35, 2015 | 4 | 2015 |
Efficacy of interventions for prevention and correction of overweight and obesity in children 7–8 years old: a meta-analysis VK Fediaeva, EA Bogova, VA Peterkova, OY Rebrova Obesity and metabolism 17 (2), 115-124, 2020 | 3 | 2020 |
Developing clinical guidelines and assessing the quality of medical care using the RAND/UCLA method OO Buzuverova, VK Fedyaeva, OA Sukhorukikh FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 12 (4 …, 2020 | 3 | 2020 |
Evolution of healthcare provider payment mechanisms VV Omelyanovskiy, NN Sisigina, VK Fedyaeva, NZ Musina FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 12 (4 …, 2020 | 3 | 2020 |
International experience in determining the cost-effectiveness thresholds TP Bezdenezhnykh, NZ Musina, VK Fedyaeva, TS Tepcova, ... FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 11 (4 …, 2019 | 3 | 2019 |
The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia VV Omelyanovsky, VK Fedyaeva, NZ Musina FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 11 (3), 3-7, 2018 | 3 | 2018 |